Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
100.4M
Cash
139M
Avg Qtr Burn
-17.52M
Short % of Float
36.44%
Insider Ownership
9.84%
Institutional Own.
-
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NGN-401 Details Rare genetic disease, Rett syndrome | Phase 1/2 Data readout | |
NGN-101 Details Rare genetic disease, Batten Disease | Failed Discontinued |